IDEXX Laboratories, Inc. (IDXX)

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

As of November 3, 2026, IDEXX Laboratories, Inc. (IDXX) stock edged higher to $674.02, up 0.35% (+$2.38) versus the previous close. On the day, shares have traded between $655.51 and $676.44. That puts IDXX around the middle of its 52-week range of $500.61 to $769.98. IDEXX Laboratories, Inc. operates in the in vitro & in vivo diagnostic substances space and carries a market capitalization of roughly $43.42 billion, with about 346.0K shares changing hands.

Latest IDXX news

• Idexx Laboratories (IDXX) Crossed Above the 200-Day Moving Average: What That Means for InvestorsYahoo Finance· Nov 3, 8:30 AM ET
• Company News for Nov 3, 2026Yahoo Finance· Nov 3, 8:22 AM ET
• US Stock Market Today: S&P 500 Futures Slip On Firm Manufacturing And Jobs FocusYahoo Finance· Nov 3, 8:13 AM ET
• Review & Preview: WhiplashYahoo Finance· Nov 2, 7:55 PM ET
• IDEXX stock soars 21.9% after earnings beat and higher outlookthestreet.com· Nov 2, 7:00 PM ET
• Non-AI stock surges 20% after earnings beat and raised outlookthestreet.com· Nov 2, 6:14 PM ET
• Earnings Calendar and Analysis for This Weekkiplinger.com· Nov 2, 5:19 PM ET
• US Equity Markets Mixed as Technology Sell-Off Continues, Crude Oil Prices DipYahoo Finance· Nov 2, 4:15 PM ET

Source: Yahoo Finance RSS · Updated November 3, 2026

Want IDXX headlines, alerts and AI research in one place? Create a free account →

• $IDXX target: $771.75

  @abramso_com· Nov 3, 9:37 AM ET· Bullish

• ☀️ Plan for Tuesday, Nov 3, before my first order. Paper account. ⏰ Late today: a power cut at my base. Still before I trade. 🌍 Equal-weight S&P +0.76% yesterday while tech fell 2.95%. Money keeps leaving AI and chips for staples, financials, healthcare. Midterms today, A…

  @rafik_ai_trader· Nov 3, 9:21 AM ET

• $IDXX Share Price: $671.84 Contract Selected: Apr 16, 2027 $670 Calls Buy Zone: $52.71 – $65.11 Target Zone: $95.73 – $117.01 Potential Upside: 72% ROI Time to Expiration: 163 Days | Updates via https://fxcapta.com/stockinfo/

  @SuperGreenToday· Nov 3, 7:59 AM ET

• $IDXX Q3 results Nov 2 before the open: revenue $1.214B (+10%), EPS $4.01 (+18%); FY26 EPS outlook raised to $14.96–15.16. Shares closed at $671.64 on Monday, above the 50-day SMA ($536.56) and above the 200-day ($572.42), near the top of its 20-day range ($501.17–$673.19). Pr…

  @Merlintrader· Nov 3, 7:44 AM ET

• $IDXX jumped about 22% on Monday, November 2, 2026 after revenue rose 10% to $1.21B and it raised its full-year revenue outlook to $4.74B-$4.77B. EPS (profit per share) was about $4.01 against roughly $3.71 expected. A stock's value is not fixed. It gets recalculated sever…

  @Techdamentals· Nov 2, 10:21 PM ET

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →